Stay updated with the latest disease-burden news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on disease-burden topics.

Qdenga vaccine against dengue (image is for representation purposes only) AI generated image ShowQuick Read Summary is AI-generated, newsroom-reviewed * Qdenga dengue vaccine expected to launch in India by 2026 after regulatory approval * Vaccine developed by Takeda Pharma, to be made in India with Biological E under Make-in-India * Qdenga requires two doses and protects against all dengue serotypes, including prior infections Did our AI summary help? Let us know. Switch To Beeps Mode ...Read More >
Chandigarh: Punjab, still recovering from the devastation caused by the recent floods, is now battling an alarming surge in vector-borne diseases. Data from the health department shows that the positivity rate of dengue, which was around 3.8% so far this year, spiked to over 11.5% in October -- nearly a threefold rise following the floods.The floods -- the worst in Punjab in decades -- ravaged nearly 2,300 villages across the state, affecting over 4 lakh people and claiming 55 lives. Water stood ...Read More >
NEW DELHI: The incidence of cancer in India has gone up by 26%, from 84.8 per 1 lakh population in 1990 to 107.2 in 2023, according to a new study. Published in The Lancet, it shows deaths due to cancer increased by 21% during this period, despite advances in treatment. In comparison, both incidence and mortality have declined significantly in US and China over the 33-year period. The reason behind this is strong tobacco control, universal vaccination and organised screening in these two countri ...Read More >

NEW DELHI: India accounts for 17% of the world's population and 20% of the global disease burden, yet fewer than four percent of international clinical trials are conducted in the country. This gap means Indian patients often wait years after global approvals to access breakthrough therapies. Now, a new initiative, aligning it with Central Drugs Standard Control Organisations (CDSCO) priorities to boost participation of government sites in Phase 3 and 4 trials, has trained nearly 400 professio ...Read More >

NEW DELHI: While delivering a thought-provoking keynote address at the Doctor's Day Conclave organized by the Times Now, Union Minister of State (Independent Charge) for Science & Technology, Dr. Jitendra Singh, who is also a noted Professor of Medicine and Diabetologist, emphasized that India stands at the crossroads of a health-tech revolution and at the threshold of a grand new chapter, with its economy moving from the 10th to the 4th largest globally and the further ascent continuing. The M ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.